Wolverine Asset Management LLC Amgen Inc Put Options Transaction History

Wolverine Asset Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $9.1 Million - $9.92 Million	-29,400 Reduced 34.63%	55,500 $17.9 Million
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $5.41 Million - $6.58 Million	20,600 Added 32.04%	84,900 $26.5 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $5.38 Million - $6.49 Million	20,000 Added 45.15%	64,300 $18.3 Million
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $383,550 - $432,689	1,500 Added 3.5%	44,300 $12.8 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $4.24 Million - $5.27 Million	-19,400 Reduced 31.19%	42,800 $11.5 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $964,215 - $1.14 Million	-4,500 Reduced 6.75%	62,200 $13.8 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $14.4 Million - $17.5 Million	63,700 Added 2123.33%	66,700 $16.1 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $687,090 - $873,030	3,000 New	3,000 $787,000

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.